Petros Pharmaceuticals Debt-to-Assets Ratio Growth & History (PTPI)

Petros Pharmaceuticals's debt-to-assets ratio was 0.01 for fiscal 2024.

View full Petros Pharmaceuticals company overview

Petros Pharmaceuticals annual debt-to-assets ratio history

Petros Pharmaceuticals annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20242024-12-310.010.01+66.53%
20232023-12-310.01−0.00−37.78%
20222022-12-310.010.00+58.66%
20212021-12-310.01−0.10−92.96%
20202020-12-310.11

Petros Pharmaceuticals debt-to-assets ratio trends

Between the periods ended 2020-12-31 and 2024-12-31, Petros Pharmaceuticals's debt-to-assets ratio decreased from 0.11 to 0.01, a change of −0.10. The latest reported quarter, Q1 2025, shows 0.41.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Petros Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about PTPI yet. Start the conversation.

Write the first post